copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
American Heart Association Journals AHA Journals at AHA Scientific Sessions 2025 Streamlining the Pathway to Publish Cardiovascular Research Learn more about Circulation 's collaboration with NEJM Circulation Representing the best in the field of cardiovascular medicine and science as well as basic science Editor-in-Chief: Joseph A Hill, MD, PhD View latest issue
2025 ACC AHA ACEP NAEMSP SCAI Guideline for the Management of Patients . . . Progressive lipid accumulation and inflammation within an atherosclerotic plaque may lead to plaque instability Rupture or erosion of the atherosclerotic plaque and exposure of plaque contents to the circulation may then culminate in activation of the coagulation cascade and subsequent thrombosis
American Heart Association Journals Circulation: Heart Failure presents Waveforms, our blog highlighting what’s new and what’s important about papers coming out in the journal Latest Posts
2025 High Blood Pressure Guidelines - AHA ASA Journals Published jointly in Hypertension and Circulation The 2025 AHA ACC High Blood Pressure Guideline reflects the latest recommendations and advancements in hypertension research and clinical practice
American Heart Association Journals Circulation Research The premier international journal in basic and translational cardiovascular biology and source for the most revolutionary research in the field
Dapagliflozin to Reduce Early Recurrence After Catheter Ablation for . . . Background: Observational studies have suggested that sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with a lower risk of atrial fibrillation (AF) recurrence after catheter ablation in AF patients with concomitant diabetes, heart failure or chronic kidney disease However, no randomized trial to date has tested whether SGLT2i reduces AF recurrence post-ablation in patients
Effects of Tirzepatide on the Clinical Trajectory of Patients With . . . Circulation 2020;141:352–361 doi: 10 1161 CIRCULATIONAHA 119 044586 8 Butler J, Packer M, Filippatos G, Ferreira JP, Zeller C, Schnee J, Brueckmann M, Pocock SJ, Zannad F, Anker SD Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction